Shilpa Medicare Expands Oncology Drug Production with Roboti

Shilpa Medicare Expands Oncology Drug Production with Robotic Pilot Line


one of the largest specialty generic pharmaceutical companies in the world. They sought a new pilot line with an extremely small footprint to process vials, pre-filled syringes (PFS), and cartridges for injectable oncology drugs. Another caveat: they wanted to system to function with very limited human intervention.
They worked with Steriline, an Italian provider of aseptic processing machinery and 10-year partner to Shilpa Medicare, to develop an innovative filling, stoppering, and capping system.
Steriline designed a robotic line composed of a semiautomatic Robotic Nest Filling Machine (RNFM1-Lab) and a Vial Capping Machine (VCM50), both able to process the three required formats. Steriline reports, “The two machines were designed to work together: they operate independently with human intervention needed to move the containers from the RNFM1-Lab to the VCM50.”

Related Keywords

Italy , Italian , Pradeep Shivkumar , Filippo Parini , Shilpa Medicare , India Based Shilpa Medicare Limited , Robotic Nest Filling Machine , Vial Capping Machine , Factory Acceptance Tests , இத்தாலி , இத்தாலிய , ஷில்பா மருத்துவ , தொழிற்சாலை ஏற்றுக்கொள்ளுதல் சோதனைகள் ,

© 2025 Vimarsana